Aizenstein M L, Korf J
Brain Res. 1978 Jun 23;149(1):129-40. doi: 10.1016/0006-8993(78)90593-0.
In rats, different methods of perfusion (lumbar-cisternal or ventricular-cisternal) with artificial cerebrospinal fluid were performed at velocities of about 30 and 180 microliter/min. Levels of homovanillic acid (HVA) in the outflow were assayed with a semiautomated fluorimetric technique. Intravenous administration of 20 microgram HVA did not substantially enhance the outflow of this acid, indicating that in our preparations HVA found in the perfusate is of central origin. In the lumbar-cisternal preparation probenecid (200 mg/kg, i.p.) was found to inhibit the efflux of a significant fraction of HVA added to the medium, at both perfusion rates. The proportions of HVA eliminated by a probenecid sensitive transport was much higher at the lower rate of perfusion. Following probenecid the increase of endogenous HVA in the ventricular-cisternal perfusate was higher at a lower rate of perfusion. We determined the turnover rate of HVA in the whole brain and compared this value with the HVA outflow in the various preparations. The highest efflux of HVA was found in the ventricular-cisternal preparation during probenecid treatment and did not appear to be dependent upon the rate of perfusion. A maximal value of 3.5% of HVA formed in the central nervous system was found to be released into the cerebrospinal fluid.
在大鼠中,采用不同的灌注方法(腰-脑池或脑室-脑池),以约30微升/分钟和180微升/分钟的流速灌注人工脑脊液。采用半自动荧光技术测定流出液中高香草酸(HVA)的水平。静脉注射20微克HVA并没有显著增加这种酸的流出量,这表明在我们的实验制剂中,灌注液中发现的HVA源自中枢。在腰-脑池灌注制剂中,发现丙磺舒(200毫克/千克,腹腔注射)在两种灌注速率下均能抑制添加到培养基中的相当一部分HVA的流出。在较低灌注速率下,经丙磺舒敏感转运消除的HVA比例更高。注射丙磺舒后,脑室-脑池灌注液中内源性HVA的增加在较低灌注速率下更高。我们测定了全脑中HVA的周转率,并将该值与各种制剂中HVA的流出量进行了比较。在丙磺舒治疗期间,脑室-脑池灌注制剂中HVA的流出量最高,且似乎不依赖于灌注速率。发现中枢神经系统中形成的HVA有3.5%的最大值释放到脑脊液中。